We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
The current SPL market cap is 53.57M. The company's latest EPS is AUD -0.0380 and P/E is -3.42.
| Year End 30 June 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Revenue | 1.66M | 6.59M | 3.13M | 4.95M | 3.07M |
| Operating Income | -15.31M | -15.2M | -20.09M | -16.37M | -16.91M |
| Net Income | -14.25M | -14.68M | -19.73M | -16.15M | -15.64M |
| Year End 30 June 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Assets | 48.86M | 39.08M | 73.24M | 66.18M | 52.09M |
| Total Liabilities | 6.46M | 7.75M | 10.94M | 17.78M | 17.27M |
| Total Equity | 42.4M | 31.33M | 62.3M | 48.39M | 34.82M |
| Year End 30 June 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Operating | -10.34M | -10.78M | -14.81M | -13.16M | -13.53M |
| Investing | -306k | -125k | -246k | -836k | -610k |
| Financing | -26k | -584k | 46.3M | 3.23M | -695k |
| Market Cap | 53.57M |
| Price to Earnings Ratio | -3.42 |
| Price to Sales Ratio | 17.33 |
| Price to Cash Ratio | 1.52 |
| Price to Book Ratio | 1.54 |
| Dividend Yield | - |
| Shares Outstanding | 412.04M |
| Average Volume (1 week) | 476.53k |
| Average Volume (1 Month) | 475.02k |
| 52 Week Change | -72.63% |
| 52 Week High | 0.53 |
| 52 Week Low | 0.12 |
| Spread (Intraday) | 0.01 (7.41%) |
| Company Name | Starpharma Holdings Limited |
| Address |
4-6 southampton cresent melbourne, victoria 3067 |
| Website | https://www.starpharma.com |
| Industry | pharmaceutical diversified (H2) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
